Fisher & Paykel Healthcare releases F&P Visairo™ hospital under-nose mask for noninvasive ventilation

Fisher & Paykel Healthcare has announced the launch of F&P Visairo, a hospital under-nose mask for noninvasive ventilation, in the United States.

F&P Visairo is a new high-performance under-nose hospital mask with dynamic support technology. This allows for bridge-free noninvasive ventilation, which eliminates pressure from the bridge of the nose and clears the way for an open field of vision, without compromising on stability and performance. Stability wings in the mask frame provide support for the floating seal to remain comfortable and stable on the patient’s face.
In trials of F&P Visairo, 96 percent of clinicians rated the mask ‘very good’ or ‘good’ for performance, and 95 percent rated it ‘very good’ or ‘good’ for comfort.1
“The feedback we have received from clinicians has been impressive,” said Dr Andrew Somervell, VP Products and Technology for Fisher & Paykel Healthcare.
“For hospital patients who require higher levels of respiratory support without intubation, Visairo provides a more comfortable experience, so the therapy is more likely to be effective. It sits comfortably on the face and allows for a clear field of vision, so patients can wear glasses, read or watch television during their treatment,” said Dr Somervell.
F&P Visairo is currently available in the U.S., New Zealand, Australia, and Europe and will be released to other regions upon receiving regulatory clearances. The mask is available in three sizes to correspond to the dimensions of the patient’s nose. Details can be found at or by contacting your local Fisher & Paykel Healthcare sales representative.

1Clinicians' responses were collected at 12 different hospitals in the U.S., Canada and Australia. Data was gathered from at least 93 responses.

F&P Visairo™ hospital under-nose mask for noninvasive ventilation



About Fisher & Paykel Healthcare

Fisher & Paykel Fisher Healthcare is a leading designer, manufacturer and marketer of products and systems for use in acute and chronic respiratory care, surgery and the treatment of obstructive sleep apnea. The company’s products are sold in more than 120 countries worldwide. For more information about the company, visit our website

Authorised by Fisher & Paykel Healthcare Corporation Limited’s Company Secretary.



Media & Investor Contacts:

Karen Knott
GM Corporate Communications
+64 (0) 21 713 911


Hayden Brown
Investor Relations Manager
+64 (0) 27 807 8073